259 related articles for article (PubMed ID: 12667223)
1. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
Stanley WC; Marzilli M
Fundam Clin Pharmacol; 2003 Apr; 17(2):133-45. PubMed ID: 12667223
[TBL] [Abstract][Full Text] [Related]
2. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
Belardinelli R
Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
[TBL] [Abstract][Full Text] [Related]
3. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
Kantor PF; Lucien A; Kozak R; Lopaschuk GD
Circ Res; 2000 Mar; 86(5):580-8. PubMed ID: 10720420
[TBL] [Abstract][Full Text] [Related]
4. Partial fatty acid oxidation inhibitors for stable angina.
Stanley WC
Expert Opin Investig Drugs; 2002 May; 11(5):615-29. PubMed ID: 11996644
[TBL] [Abstract][Full Text] [Related]
5. Metabolic therapy for the diabetic patients with ischaemic heart disease.
Rosano GM; Vitale C; Volterrani M; Fini M
Coron Artery Dis; 2005 Nov; 16 Suppl 1():S17-21. PubMed ID: 16340399
[TBL] [Abstract][Full Text] [Related]
6. Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies.
Stanley WC
J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S31-45. PubMed ID: 15378130
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
McClellan KJ; Plosker GL
Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine for stable angina pectoris.
Cross HR
Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
[TBL] [Abstract][Full Text] [Related]
9. Metabolic management of ischemic heart disease: clinical data with trimetazidine.
Desideri A; Celegon L
Am J Cardiol; 1998 Sep; 82(5A):50K-53K. PubMed ID: 9737486
[TBL] [Abstract][Full Text] [Related]
10. Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study.
Chazov EI; Lepakchin VK; Zharova EA; Fitilev SB; Levin AM; Rumiantzeva EG; Fitileva TB
Am J Ther; 2005; 12(1):35-42. PubMed ID: 15662290
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase.
Lopaschuk GD; Barr R; Thomas PD; Dyck JR
Circ Res; 2003 Aug; 93(3):e33-7. PubMed ID: 12869392
[TBL] [Abstract][Full Text] [Related]
12. Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.
Stanley WC; Sabbah HN
Heart Fail Rev; 2005 Dec; 10(4):275-9. PubMed ID: 16583175
[No Abstract] [Full Text] [Related]
13. [Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism].
Lopaschuk GD
Presse Med; 1998 Dec; 27(39):2100-4. PubMed ID: 9893703
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents.
Jackson G
Int J Clin Pract; 2001 May; 55(4):256-61. PubMed ID: 11406911
[TBL] [Abstract][Full Text] [Related]
15. Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up.
Xu X; Zhang W; Zhou Y; Zhao Y; Liu Y; Shi D; Zhou Z; Ma H; Wang Z; Yu M; Ma Q; Gao F; Shen H; Zhang J
Clin Drug Investig; 2014 Apr; 34(4):251-8. PubMed ID: 24470342
[TBL] [Abstract][Full Text] [Related]
16. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism.
Lopaschuk GD
Am J Cardiol; 1998 Sep; 82(5A):14K-17K. PubMed ID: 9737481
[TBL] [Abstract][Full Text] [Related]
17. Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.
Dézsi CA
Am J Ther; 2016; 23(3):e871-9. PubMed ID: 25756467
[TBL] [Abstract][Full Text] [Related]
18. Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies.
Szwed H; Hradec J; Préda I
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S25-8. PubMed ID: 11286304
[TBL] [Abstract][Full Text] [Related]
19. Metabolic energy metabolism in diabetes: therapeutic implications.
Pogatsa G
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S29-33. PubMed ID: 11286305
[TBL] [Abstract][Full Text] [Related]
20. [Efficiency of trimetazidine treatment of experimental ischemic heart disease in age aspect].
Kukes VG; Zhernakova NI; Gorbach TV; Romashchenko OV; Rumbesht VV
Eksp Klin Farmakol; 2013; 76(2):9-12. PubMed ID: 23631276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
